GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 215 filers reported holding GENOMIC HEALTH INC in Q2 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $818,000 | -78.6% | 12,063 | -81.7% | 0.24% | -71.9% |
| Q2 2019 | $3,825,000 | +72.4% | 65,753 | +107.6% | 0.87% | +75.4% |
| Q1 2019 | $2,219,000 | +9.9% | 31,677 | +1.0% | 0.50% | +1.2% |
| Q4 2018 | $2,020,000 | -45.2% | 31,359 | -40.3% | 0.49% | -28.6% |
| Q3 2018 | $3,687,000 | +1.1% | 52,508 | -27.4% | 0.68% | -2.8% |
| Q2 2018 | $3,646,000 | +44.1% | 72,340 | -10.6% | 0.70% | +49.7% |
| Q1 2018 | $2,531,000 | -19.8% | 80,903 | -12.3% | 0.47% | -28.1% |
| Q4 2017 | $3,156,000 | +19.2% | 92,279 | +11.8% | 0.66% | -11.2% |
| Q3 2017 | $2,648,000 | +1.5% | 82,503 | +3.0% | 0.74% | -4.3% |
| Q2 2017 | $2,608,000 | +3.9% | 80,135 | +0.6% | 0.77% | +23.0% |
| Q1 2017 | $2,510,000 | – | 79,693 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $56,620,000 | 5.32% |
| Baker Brothers Advisors | 13,655,618 | $386,590,000 | 4.87% |
| NORTH TIDE CAPITAL, LLC | 1,500,000 | $42,465,000 | 3.24% |
| Murphy Michael R | 291,292 | $8,246,000 | 2.85% |
| Tributary Capital Management, LLC | 111,244 | $3,149,000 | 0.66% |
| Champlain Investment Partners, LLC | 1,234,780 | $34,957,000 | 0.61% |
| IRONBRIDGE CAPITAL MANAGEMENT LP | 454,085 | $12,855,000 | 0.34% |
| STONEBRIDGE CAPITAL MANAGEMENT INC | 27,180 | $769,000 | 0.30% |
| Motley Fool Asset Management LLC | 36,179 | $1,139,000 | 0.24% |
| Kimelman & Baird, LLC | 35,800 | $1,013,000 | 0.19% |